Cargando…

Recent advances in transfusions in neonates/infants

Transfusions of red blood cells (RBCs), platelets, and plasma are critical therapies for infants and neonates (particularly preterm neonates) in the neonatal intensive care unit, who are the most frequently transfused subpopulation across all ages. Although traditionally a significant gap has existe...

Descripción completa

Detalles Bibliográficos
Autores principales: Goel, Ruchika, Josephson, Cassandra D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964626/
https://www.ncbi.nlm.nih.gov/pubmed/29904575
http://dx.doi.org/10.12688/f1000research.13979.1
_version_ 1783325214272126976
author Goel, Ruchika
Josephson, Cassandra D.
author_facet Goel, Ruchika
Josephson, Cassandra D.
author_sort Goel, Ruchika
collection PubMed
description Transfusions of red blood cells (RBCs), platelets, and plasma are critical therapies for infants and neonates (particularly preterm neonates) in the neonatal intensive care unit, who are the most frequently transfused subpopulation across all ages. Although traditionally a significant gap has existed between the blood utilization and the evidence base essential to adequately guide transfusion practices in infants and neonates, pediatric transfusion medicine is evolving from infancy and gradually coming of age. It is entering an exciting era with recognition as an independent discipline, a new and evolving high-quality evidence base for transfusion practices, novel technologies and therapeutics, and national/international collaborative research, educational, and clinical efforts. Triggers and thresholds for red cell transfusion are accumulating evidence with current phase III clinical trials. Ongoing trials and studies of platelet and plasma transfusions in neonates are anticipated to provide high-quality evidence in years to come. This article aims to summarize the most current evidence-based practices regarding blood component therapy in neonates. Data on the use of specific components (RBCs, plasma, and platelets) are provided. We attempt to define thresholds for anemia, thrombocytopenia, and abnormal coagulation profile in neonates to highlight the difficulties in having a specific cutoff value in neonates and preterm infants. Indications for transfusion of specific products, transfusion thresholds, and current practices and guidelines are provided, and possible adverse outcomes and complications are discussed. Finally, the critical research knowledge gaps in these practices as well as ongoing and future research areas are discussed. In an era of personalized medicine, neonatal transfusion decisions guided by a strong evidence base must be the overarching goal, and this underlies all of the strategic initiatives in pediatric and neonatal transfusion research highlighted in this article.
format Online
Article
Text
id pubmed-5964626
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-59646262018-06-13 Recent advances in transfusions in neonates/infants Goel, Ruchika Josephson, Cassandra D. F1000Res Review Transfusions of red blood cells (RBCs), platelets, and plasma are critical therapies for infants and neonates (particularly preterm neonates) in the neonatal intensive care unit, who are the most frequently transfused subpopulation across all ages. Although traditionally a significant gap has existed between the blood utilization and the evidence base essential to adequately guide transfusion practices in infants and neonates, pediatric transfusion medicine is evolving from infancy and gradually coming of age. It is entering an exciting era with recognition as an independent discipline, a new and evolving high-quality evidence base for transfusion practices, novel technologies and therapeutics, and national/international collaborative research, educational, and clinical efforts. Triggers and thresholds for red cell transfusion are accumulating evidence with current phase III clinical trials. Ongoing trials and studies of platelet and plasma transfusions in neonates are anticipated to provide high-quality evidence in years to come. This article aims to summarize the most current evidence-based practices regarding blood component therapy in neonates. Data on the use of specific components (RBCs, plasma, and platelets) are provided. We attempt to define thresholds for anemia, thrombocytopenia, and abnormal coagulation profile in neonates to highlight the difficulties in having a specific cutoff value in neonates and preterm infants. Indications for transfusion of specific products, transfusion thresholds, and current practices and guidelines are provided, and possible adverse outcomes and complications are discussed. Finally, the critical research knowledge gaps in these practices as well as ongoing and future research areas are discussed. In an era of personalized medicine, neonatal transfusion decisions guided by a strong evidence base must be the overarching goal, and this underlies all of the strategic initiatives in pediatric and neonatal transfusion research highlighted in this article. F1000 Research Limited 2018-05-18 /pmc/articles/PMC5964626/ /pubmed/29904575 http://dx.doi.org/10.12688/f1000research.13979.1 Text en Copyright: © 2018 Goel R and Josephson CD http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Goel, Ruchika
Josephson, Cassandra D.
Recent advances in transfusions in neonates/infants
title Recent advances in transfusions in neonates/infants
title_full Recent advances in transfusions in neonates/infants
title_fullStr Recent advances in transfusions in neonates/infants
title_full_unstemmed Recent advances in transfusions in neonates/infants
title_short Recent advances in transfusions in neonates/infants
title_sort recent advances in transfusions in neonates/infants
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964626/
https://www.ncbi.nlm.nih.gov/pubmed/29904575
http://dx.doi.org/10.12688/f1000research.13979.1
work_keys_str_mv AT goelruchika recentadvancesintransfusionsinneonatesinfants
AT josephsoncassandrad recentadvancesintransfusionsinneonatesinfants